The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of 223Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients.
Bosch D, van der Velden KJM, Oving IM, Wyndaele DNJ, Weijs LE, van Schelven WD, Oyen WJG, Te Beek ET, van de Luijtgaarden ACM, Somford DM, Nagarajah J, Hermsen R, Mehra N, Gerritsen WR, van der Doelen MJ, van Oort IM.
Bosch D, et al. Among authors: van schelven wd.
J Nucl Med. 2024 Apr 1;65(4):541-547. doi: 10.2967/jnumed.123.266654.
J Nucl Med. 2024.
PMID: 38423781